ANTIMICROBIAL RESISTANCE SOLUTIONS
WITH DR. JOHN H. REX
Latest Newsletters
Latest Government Action





















R&D Insight
Can you help?
Antimicrobial resistance poses a catastrophic threat. If we don’t act now, any one of us could go into hospital in 20 years for minor surgery and die because of an ordinary infection that can’t be treated by antibiotics. And routine operations like hip replacements or organ transplants could be deadly because of the risk of infection.
Dame Sally Davies Tweet
New mechanisms for antibiotic reimbursement in the United States: CMS’s IPPS FY2020 Final Rule
What does an antibiotic cost to develop? What is it worth? How to afford it?
Push! Pull! Push! Pull! / Highlights from Davos 2018
NIAID workshop: What is a robust PK-PD package?
Draft EMA antibacterial guidance: Analysis
How hard (and how) to Pull? Net value of Pull via a Transferrable Exclusivity Extension (TEE)
Plazomicin EU marketing application is withdrawn: Near zero market value of newly approved antibacterials
Mirror Bacteria: An AMR threat of unprecedented magnitude
Global survey of novel antibiotic reimbursement models / PASTEUR Act introduced to US House
Developing antibiotics for children: There are no easy answers
Categories of resistance: MDR, XDR, PDR, UDR, and (new!) DTR
Two new oral drugs for gonorrhea!
The thoughtless person playing with penicillin treatment is morally responsible for the death of the man who succumbs to infection with the penicillin-resistant organism.
Alexander Fleming Tweet
The bipartisan PASTEUR Act is the strongest bill ever written to strengthen antibiotic development and use. It will fix our market failures, expand the pipeline for next generation antibiotics, and save lives. We can’t sit on our hands as this public health crisis arrives – we have to act now.
U.S. Senator Michael Bennet Tweet